Bionano Genomics (BNGO) Shares Outstanding (Diluted Average) (2020 - 2025)
Bionano Genomics (BNGO) has disclosed Shares Outstanding (Diluted Average) for 6 consecutive years, with $5.4 million as the latest value for Q4 2025.
- Quarterly Shares Outstanding (Diluted Average) rose 328.4% to $5.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.4 million through Dec 2025, up 328.4% year-over-year, with the annual reading at $5.4 million for FY2025, 328.4% up from the prior year.
- Shares Outstanding (Diluted Average) hit $5.4 million in Q4 2025 for Bionano Genomics, up from $3.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $284.6 million in Q1 2022 to a low of $569000.0 in Q4 2023.
- Historically, Shares Outstanding (Diluted Average) has averaged $79.2 million across 5 years, with a median of $28.6 million in 2022.
- Biggest five-year swings in Shares Outstanding (Diluted Average): plummeted 98.03% in 2023 and later skyrocketed 328.4% in 2025.
- Year by year, Shares Outstanding (Diluted Average) stood at $276.8 million in 2021, then plummeted by 89.55% to $28.9 million in 2022, then tumbled by 98.03% to $569000.0 in 2023, then surged by 123.37% to $1.3 million in 2024, then surged by 328.4% to $5.4 million in 2025.
- Business Quant data shows Shares Outstanding (Diluted Average) for BNGO at $5.4 million in Q4 2025, $3.8 million in Q3 2025, and $3.1 million in Q2 2025.